Purpose: To evaluate differences in health related quality of life and time to return to normal activities between patients treated with open radical prostatectomy (ORP) and robot-assisted radical prostatectomy (RARP). Patients and Methods: Three hundred and two patients treated with RARP or ORP were prospectively enrolled. One year after surgery, patients received a questionnaire to evaluate social life, duration of being limited in daily and sexual life as well as satisfaction with the treatment. Results: Both cohorts showed no differences in age, prostate specific-antigen-levels, Gleason score, prostate volume or T-stage (p > 0.05). Median blood loss was significant lower and the surgical time was significant higher in the RARP group. There were no significant differences regarding the duration of being limited in social or daily life or regarding the satisfaction with the treatment. The median time patients felt affected in their work was 2 months. There were no significant differences in terms of subjective global health status and HrQoL 3 months (p = 0.60 and p = 0.40) and 6 months (p = 0.30 and p = 0.20) after surgery. Conclusion: The present study confirms significant perioperative benefits for patients undergoing RARP compared to ORP. However, there is no difference in HrQoL as well as in the time to return to normal activities between patients treated with RARP and ORP.

Keywords:
Prostate cancer, Robot-assisted prostatectomy, Functional outcomes, Quality of life
1.
Coelho RF, Rocco B, Patel MB, Orvieto MA, Chauhan S, Ficarra V, Melegari S, Palmer KJ, Patel VR: Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol 2010;24:2003-2015.
2.
Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Ruutu M, Bill-Axelson A; SPCG-4 Investigators: Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian prostate cancer group-4 randomised trial. Lancet Oncol 2011;12:891-899.
3.
Woo SH, Kang DI, Ha YS, Salmasi AH, Kim JH, Lee DH, Kim WJ, Kim IY: Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomy. J Endourol 2014;28:172-177.
4.
Barnoiu OS, Garcia Galisteo E, Baron Lopez F, Vozmediano Chicharro R, Soler Martinez J, Del Rosal Samaniego JM, Machuca Santacruz J, Baena Gonzalez V: Prospective urodynamic model for prediction of urinary incontinence after robot-assisted radical prostatectomy. Urol Int 2014;92:306-309.
5.
Campodonico F, Manuputty EE, Campora S, Puntoni M, Maffezzini M: Age is predictive of immediate postoperative urinary continence after radical retropubic prostatectomy. Urol Int 2014;92:276-281.
6.
Yasui T, Tozawa K, Kurokawa S, Okada A, Mizuno K, Umemoto Y, Kawai N, Sasaki S, Hayashi Y, Kojima Y, Kohri K: Impact of prostate weight on perioperative outcomes of robot-assisted laparoscopic prostatectomy with a posterior approach to the seminal vesicle. BMC Urol 2014;14:6.
7.
Finkelstein J, Eckersberger E, Sadri H, Taneja SS, Lepor H, Djavan B: Open versus laparoscopic versus robot-assisted laparoscopic prostatectomy: the European and US experience. Rev Urol 2010;12:35-43.
8.
Musch M, Roggenbuck U, Klevecka V, Loewen H, Janowski M, Davoudi Y, Kroepfl D: Does changeover by an experienced open prostatic surgeon from open retropubic to robot-assisted laparoscopic prostatectomy mean a step forward or backward? ISRN Oncol 2013;2013:768647.
9.
Ahlering TE, Woo D, Eichel L, Lee DI, Edwards R, Skarecky DW: Robot-assisted versus open radical prostatectomy: a comparison of one surgeon's outcomes. Urology 2004;63:819-822.
10.
Drummond FJ, Kinnear H, O'Leary E, Donnelly, Gavin A, Sharp L: Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the picture (prostate cancer treatment, your experience) study. J Cancer Surviv 2015;9:361-372.
11.
Lennernäs B, Majumder K, Damber JE, Albertsson P, Holmberg E, Brandberg Y, Isacsson U, Ljung G, Damm O, Nilsson S: Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: a Swedish multicenter randomized trial with patient-reported outcomes. Acta Oncol 2015;54:875-881.
12.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
13.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al: The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
14.
van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D'Haese S, Aaronson NK: An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 2008;44:2418-2424.
15.
Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M, Guazzoni G, Guillonneau B, Menon M, Montorsi F, Patel V, Rassweiler J, Van Poppel H: Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009;55:1037-1063.
16.
Park J, Yoo DS, Song C, Park S, Park S, Kim SC, Cho Y, Ahn H: Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. World J Urol 2014;32:193-199.
17.
Litwin MS, Melmed GY, Nakazon T: Life after radical prostatectomy: a longitudinal study. J Urol 2001;166:587-592.
18.
Bhayani SB, Pavlovich CP, Hsu TS, Sullivan W, Su L: Prospective comparison of short-term convalescence: laparoscopic radical prostatectomy versus open radical retropubic prostatectomy. Urology 2003;61:612-616.
19.
Kouba E, Hubbard JS, Moore D, Wallen EM, Pruthi RS: A prospective evaluation of the short-term impact and recovery of health-related quality of life in men undergoing radical prostatectomy. BJU Int 2007;99:72-76.
20.
Ficarra V, Novara G, Galfano A, Stringari C, Baldassarre R, Cavalleri S, Artibani W: Twelve-month self-reported quality of life after retropubic radical prostatectomy: a prospective study with rand 36-item health survey (short form-36). BJU Int 2006;97:274-278.
21.
Treiyer A, Anheuser P, Bütow Z, Steffens J: A single center prospective study: prediction of postoperative general quality of life, potency and continence after radical retropubic prostatectomy. J Urol 2011;185:1681-1685.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.